cytidine has been researched along with Grippe in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 5 (100.00) | 2.80 |
Authors | Studies |
---|---|
Boschi, D; Gribaudo, G; Lolli, ML; Luganini, A; Sainas, S; Sibille, G | 1 |
Hampton, T | 1 |
Hart, M; Natchus, MG; Painter, GR; Plemper, RK; Toots, M; Yoon, JJ | 1 |
Plemper, RK; Toots, M | 1 |
Dolgin, E | 1 |
1 review(s) available for cytidine and Grippe
Article | Year |
---|---|
Next-generation direct-acting influenza therapeutics.
Topics: Amides; Antibodies, Neutralizing; Antiviral Agents; Cytidine; Dibenzothiepins; Drug Resistance, Viral; Humans; Hydroxylamines; Influenza, Human; Morpholines; Neuraminidase; Oxazines; Pyrazines; Pyridines; Pyridones; Ribonucleosides; RNA-Dependent RNA Polymerase; Thiepins; Triazines; Virus Replication | 2020 |
4 other study(ies) available for cytidine and Grippe
Article | Year |
---|---|
The Novel
Topics: Antiviral Agents; Cytidine; Dihydroorotate Dehydrogenase; Dipyridamole; Enzyme Inhibitors; Humans; Influenza, Human; Orthomyxoviridae Infections; Pyrimidines; Uridine; Virus Replication | 2022 |
New Flu Antiviral Candidate May Thwart Drug Resistance.
Topics: Animals; Antiviral Agents; Cytidine; Disease Models, Animal; Drug Resistance, Viral; Humans; Hydroxylamines; Influenza, Human; Macaca; Ribonucleosides | 2020 |
Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model.
Topics: Animals; Antiviral Agents; Cytidine; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Resistance, Viral; Ferrets; HEK293 Cells; Humans; Hydroxylamines; Influenza A virus; Influenza, Human; Madin Darby Canine Kidney Cells; Mutation; Ribonucleosides | 2020 |
The race for antiviral drugs to beat COVID - and the next pandemic.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Birds; Clinical Trials as Topic; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytidine; Drug Development; Drug Industry; Europe; Humans; Hydroxylamines; Indoles; Influenza, Human; Leucine; Orthomyxoviridae; Pandemics; Pyrrolidinones; Severe Acute Respiratory Syndrome; Strategic Stockpile; United States | 2021 |